BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 35133639)

  • 21. Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.
    Stokłosa I; Więckiewicz G; Stokłosa M; Piegza M; Pudlo R; Gorczyca P
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
    Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
    Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of Evidence-Based Strategies to Treat Alcohol Use Disorder.
    Worley J
    J Psychosoc Nurs Ment Health Serv; 2021 Dec; 59(12):7-11. PubMed ID: 34846245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
    Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
    Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review.
    Rosenstand NJ; Nielsen AS; Skøt L; Anhøj S; Nielsen DG; Højlund M; Mellentin AI
    Curr Neuropharmacol; 2024; 22(6):1129-1143. PubMed ID: 36582063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.
    Köhne S; Hillemacher T; Glahn A; Bach P
    Expert Opin Emerg Drugs; 2024 Apr; ():1-14. PubMed ID: 38606899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
    Kelty E; Terplan M; Greenland M; Preen D
    Drugs; 2021 May; 81(7):739-748. PubMed ID: 33830479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medications for Alcohol Use Disorder.
    Poorman E; McQuade BM; Messmer S
    Am Fam Physician; 2024 Jan; 109(1):71-78. PubMed ID: 38227873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
    Vannier AGL; Shay JES; Fomin V; Patel SJ; Schaefer E; Goodman RP; Luther J
    JAMA Netw Open; 2022 May; 5(5):e2213014. PubMed ID: 35594048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Heilig M; Egli M
    Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New pharmacological approaches for the treatment of alcoholism.
    Soyka M; Roesner S
    Expert Opin Pharmacother; 2006 Dec; 7(17):2341-53. PubMed ID: 17109610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.